The established method for investigating the immediate and short-term risks for a drug, after sufficient animal studies have been completed, is the phase 1 trial, which measures responses to ...

When determining the types of patients to be recruited for the trial, there was concern that the benefits of chelation might not be easily discerned if the participants were too healthy; patients who ...

In March 1999, ACAM presidents L. Terry Chappell and Ted Rozema shilled for chelation at a hearing of the House Committee on Government Reform, chaired by a powerful "health freedom" ally and veteran ...